Thorax · 2011 · 70 citations · 22 references
Inhalant exposure reduction with TLA improves quality of life, airway inflammation and systemic allergy in patients with persistent atopic asthma. TLA may be a treatment option for patients with inadequately controlled persistent atopic asthma. Trial registration number Clinical Trials NCT00986323.
22
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
Romain Pauwels · Arerugī/Arerugi · 1996 · 10.1K citations
American Journal of Respiratory and Critical Care Medicine · 2005 · 3.1K citations